Searchable abstracts of presentations at key conferences in endocrinology

ea0050p241 | Neoplasia, Cancer and Late Effects | SFEBES2017

Population remodeling in the acquisition of endocrine resistance in breast cancer

Hu Rong , Sengupta Surojeet , Sevigny Catherine , Zhang Zhen , Wang Yue , Clarke Robert

The cell-cell interactions that occur within the breast tumor microenvironment are critical determinants of cancer cell fate. In the face of treatment, the theory of clonal evolution dominates current thinking. Thus, individual cells may acquire a mutation(s) that provides a selection advantage, i.e., Darwinian selection acts at the single cell level. We studied the effect of antiestrogen treatment on the population remodeling ...

ea0050p241 | Neoplasia, Cancer and Late Effects | SFEBES2017

Population remodeling in the acquisition of endocrine resistance in breast cancer

Hu Rong , Sengupta Surojeet , Sevigny Catherine , Zhang Zhen , Wang Yue , Clarke Robert

The cell-cell interactions that occur within the breast tumor microenvironment are critical determinants of cancer cell fate. In the face of treatment, the theory of clonal evolution dominates current thinking. Thus, individual cells may acquire a mutation(s) that provides a selection advantage, i.e., Darwinian selection acts at the single cell level. We studied the effect of antiestrogen treatment on the population remodeling ...

ea0099p571 | Thyroid | ECE2024

Enhanced predictive validity of integrative models for refractory hyperthyroidism considering baseline and early therapy characteristics: a prospective cohort study

Wang Xinpan , Li Tiantian , Li Yue , Wang Qiuyi , Cai Yun , Wang Zhixiao , Shi Yun , Yang Tao , Zheng Xuqin

Background: A subset of GravesÂ’ disease (GD) patients develops refractory hyperthyroidism, posing challenges in treatment decisions. The predictive value of baseline characteristics and early therapy indicators in identifying high risk individuals is an area worth exploration.Methods: A prospective cohort study (2018-2022) involved 597 newly diagnosed adult GD patients undergoing methimazole (MMI) treatment. Baseline characteristics and 3-month ther...